Radiation-induced glioblastoma in a medulloblastoma patient: A case report with molecular features

Neuropathology

Volumn 28, Issue 6, 2008, Pages 633-639

  Gessi, Marco ^a   Maderna, Emanuela ^a   Guzzetti, Sara ^a   Cefalo, Graziella ^b   Massimino, Maura ^b   Solero, Carlo L ^a   Finocchiaro, Gaetano ^a   Pollo, Bianca ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Loss of heterozygosity; Medulloblastoma; MGMT; p53; Radiation induced glioblastoma

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53;

ADOLESCENT; ANAMNESIS; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME 17P; CHROMOSOME 19Q; GENE MUTATION; GENETIC ANALYSIS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; PRIORITY JOURNAL; RADIATION INJURY; SCHOOL CHILD;

ADOLESCENT; CHILD; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 19; DNA METHYLATION; GENE AMPLIFICATION; GENES, P53; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MEDULLOBLASTOMA; MUTATION; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROMOTER REGIONS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 54849422422     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2008.00900.x     Document Type: Article

References (34)

1. Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW. Medulloblastoma. In : Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System. Lyon : IARC Press, 2007 132 140.
2. Brat DJ, James CD, Jedlicka AE et al. Molecular genetic alterations in radiation induced astrocytoma. Am J Pathol 1999 154 : 1431 1438.
3. Donson AM, Erwin NS, Kleinschmidt-DeMasters BK, Madden JR, Addo-Yobo SO, Foreman NK. Unique molecular characteristics of radiation-induced glioblastomas. J Neuropathol Exp Neurol 2007 66 : 740 749.
4. Kleriga E, Sher JH, Nallainathan SK, Stein SC, Sacher M. Development of cerebellar malignant astrocytoma at site of a medulloblastoma treated 11 years earlier. Case Report. J Neurosurg 1978 49 : 445 449.
5. Cohen MS, Kushner MJ, Dell S. Frontal lobe astrocytoma following radiotherapy for medulloblastoma. Neurology 1981 31 : 616 619.
6. Furuta T, Sugiu K, Tamiya T, Matsumoto K, Ohmoto T. Malignant cerebellar astrocytoma developing 15 years after radiation therapy for a medulloblastoma. Clin Neurol Neurosurg 1998 100 : 56 59.
7. Nakamizo A, Nishio S, Inamura T et al. Evolution of malignant cerebellar astrocytoma at the site of a treated medulloblastoma: report of two cases. Acta Neurochir 2001 43 : 697 700.
8. Osumi AK, Mclendon RE, Tien RD et al. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma. Clin Neuropathol 1994 13 : 281 285.
9. Pearl GS, Mirra SS, Miles ML. Glioblastoma multiforme occurring 13 years after treatment of a medulloblastoma. Neurosurgery 1980 6 : 546 551.
10. Safneck JR, Napier LB, Halliday WC. Malignant astrocytoma of the optic nerve in a child. Can J Neurol Sci 1992 19 : 498 503.
11. Schmidbauer M, Budka H, Bruckner R, Vorkapic P. Glioblastoma developing at the site of a cerebellar medulloblastoma treated 6 years earlier. Case report. J Neurosurg 1987 67 : 915 918.
12. Yang SY, Wang KC, Cho BK et al. Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma. J Neurosurg 2005 102 : 417 422.
13. Laurent JP, Chang CH, Cohen ME. A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 1985 56 : 1807 1809.
14. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999 59 : 793 797.
15. Tenan M, Colombo BC, Pollo B, Cajola L, Broggi G, Finocchiaro G. p53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomas. Cancer Genet Cytogenet 1994 74 : 139 143.
16. Ohgaki H. Genetic pathways to glioblastomas. Neuropathology 2005 2 : 1 7.
17. Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases 1948. Cancer 1998 82 : 8 34.
18. Sure U, Ruedi D, Tachibana O et al. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 1997 56 : 782 789.
19. Fogelfeld L, Bauer TK, Schneider AB, Swartz JE, Zitman R. p53 gene mutations in radiation-induced thyroid cancer. J Clin Endocrinol Metab 1996 81 : 3039 3044.
20. Joachim T, Ram Z, Rappaport ZH et al. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 2001 94 : 218 221.
21. Nakanishi H, Tomita Y, Myoui A et al. Mutation of the p53 gene in postradiation sarcoma. Lab Invest 1998 78 : 727 733.
22. Di Cioccio RA, Werness BA, Peng R, Allen HJ, Piver MS. Correlation of TP53 mutations and p53 expression in ovarian tumors. Cancer Genet Cytogenet 1998 105 : 93 102.
23. Kashiwazaki H, Tonoki H, Tada M et al. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 1997 15 : 2667 2674.
24. Nakamura M, Yang F, Fujisawa H, Yonekawa Y, Kleihues P, Ohgaki H. Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J Neuropathol Exp Neurol 2000 59 : 539 543.
25. Zainuddin N, Jaafart H, Isa MN, Abdullah JM. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma. Neurol Res 2004 26 : 88 92.
26. Soejima H, Zhao W, Mukai T. Epigenetic silencing of the MGMT gene in cancer. Biochem Cell Biol 2005 83 : 429 437.
27. Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005 352 : 997 1003.
28. Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H. Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G : C- > A : T mutations of the TP53 tumor suppressore gene. Carcinogenesis 2001 22 : 1715 1719.
29. Kaup S, Grandjean V, Mukherjee R et al. Radiation-induced genomic instability is associated with DNA methylation changes in cultured human keratinocytes. Mutat Res 2006 597 : 87 97.
30. Koturbash I, Pogribny I, Kovalchuk O. Stable loss of global DNA methylation in the radiation-target tissue-a possible mechanism contributing to radiation carcinogenesis? Biochem Biophys Res Commun 2005 337 : 526 533.
31. Loree J, Koturbash I, Kutanzi K, Baker M, Pogribny I, Kovalchuk O. Radiation-induced molecular changes in rat mammary tissue: possible implications for radiation-induced carcinogenesis. Int J Radiat Biol 2006 82 : 805 815.
32. Grombacher T, Mitra S, Kaina B. Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. Carcinogenesis 1996 17 : 2329 2336.
33. Kovalchuk O, Burke P, Besplug J, Slovack M, Filkowski J, Pogribny I. Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat Res 2004 548 : 75 84.
34. Donson AM, Addo-Yobo SO, Handler M, Gore L, Foreman NK. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer 2006 48 : 403 407.